These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 976287)

  • 1. Reproductive survival in vitro of recently explanted human tumour cells following exposure to vinblastine. A suggestion for improved clinical dose schedules.
    Wells J; Berry RJ; Laing AH
    Eur J Cancer (1965); 1976 Oct; 12(10):793-6. PubMed ID: 976287
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells.
    Hanson JA; Bean EA; Coombs AM; Moore JL
    Br J Cancer; 1985 Oct; 52(4):637-40. PubMed ID: 4063141
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro.
    Rupniak HT; Whelan RD; Hill BT
    Int J Cancer; 1983 Jul; 32(1):7-12. PubMed ID: 6683250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic modification of drug effectiveness for reproductive death of cultured mammalian cells.
    Joshi DS; Barendsen GW
    Indian J Exp Biol; 1984 May; 22(5):251-4. PubMed ID: 6480057
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro study of cytotoxic activity of vinblastine in a free form and associated with nanoparticles.
    Simeonova M; Antcheva M
    Acta Physiol Pharmacol Bulg; 1994; 20(2):31-5. PubMed ID: 7725930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of gamma irradiation and vinblastine on transplanted leukemia cells in mice].
    Khenkin EV
    Vopr Onkol; 1974; 20(9):90-4. PubMed ID: 4428661
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of cytotoxicity and mitotic spindle dissolution by vinblastine in mammalian cells.
    Tucker RW; Owellen RJ; Harris SB
    Cancer Res; 1977 Dec; 37(12):4346-51. PubMed ID: 922725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin is synergistic with vinblastine in human colonic tumor cell lines: effect of cell density and timing of drug delivery.
    Frommel TO
    Anticancer Res; 1997; 17(3C):2065-71. PubMed ID: 9216665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental antitumor activity of Navelbine.
    Cros S; Wright M; Morimoto M; Lataste H; Couzinier JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):15-20. PubMed ID: 2711203
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
    Zeffren J; Yagoda A; Kelsen D; Winn R
    Anticancer Res; 1984; 4(6):411-3. PubMed ID: 6517534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of colchicine, vinblastine and cytochalasin B on human lymphocyte transformation by phytohemagglutinin.
    Medrano E; Piras R; Mordoh J
    Exp Cell Res; 1974 Jun; 86(2):295-300. PubMed ID: 4842344
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of vinblastine on the bone marrow cells of mice].
    Baisogolov GD; Konopliannikov AG; Khenkin EV
    Vopr Onkol; 1973; 19(4):52-4. PubMed ID: 4722822
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I evaluation of divided-dose vinblastine sulfate.
    Schulman P; Budman DR; Vinciguerra V; Degnan TJ
    Cancer Chemother Pharmacol; 1980; 5(1):67-9. PubMed ID: 7460196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spheroids for studies of drug effects.
    Nederman T; Twentyman P
    Recent Results Cancer Res; 1984; 95():84-102. PubMed ID: 6396762
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.
    Soudon J; Berlion M; Lucas C; Haddad P; Bizzari JP; Calvo F
    Cancer Chemother Pharmacol; 1995; 36(3):195-203. PubMed ID: 7781138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
    Erjala K; Raitanen M; Kulmala J; Grénman R
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effectiveness of bolus versus split dose vinblastine treatment in EAT tumors in mice.
    Cemazar M; Sersa G; Auersperg M
    Anticancer Res; 1997; 17(6D):4553-6. PubMed ID: 9494567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of vinblastine on endothelial cells.
    Gallagher H; Carroll WM; Dowd M; Rochev Y
    Endothelium; 2008; 15(1):9-15. PubMed ID: 18568941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-day continuous-infusion vinblastine in the treatment of breast cancer.
    Fraschini G; Yap HY; Hortobagyi GN; Buzdar A; Blumenschein G
    Cancer; 1985 Jul; 56(2):225-9. PubMed ID: 4005794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
    Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
    Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.